Kamomis is a botulinum toxin type A made by Maypharm in South Korea, sold in a 100-unit vial. Its distinctive feature is that it is vacuum-dried rather than freeze-dried, which the manufacturer ties to claims about purity and consistency. The official guide is below for your records.
What is Kamomis, and what does “vacuum-dried” mean?
Kamomis is a 100-unit botulinum toxin type A from Maypharm. Most toxins are freeze-dried (lyophilized), where the product is frozen and the water removed under low pressure. Kamomis uses vacuum drying instead. The manufacturer states this leaves minimal powder residue in the vial and aims for higher purity and batch-to-batch consistency.
Maypharm also reports that vacuum drying reduces denaturation and foaming when a professional reconstitutes the product, and suggests it may lower immunogenicity risk. Read those as the manufacturer’s rationale, not settled fact. The product contains human serum albumin and sodium chloride as excipients, and Maypharm reports stability holding within 95 to 105% of labeled potency over 12 months.
Log Notes. This explains what Kamomis is and its drying method, not how to use it. It gives no doses, units, dilution, injection points, depth, or frequency, all of which live in the official guide and belong to a licensed professional. Nothing here is medical advice, and this is not a do-it-yourself procedure.
How does botulinum toxin type A work?
It temporarily relaxes the muscle it targets. Botulinum toxin type A blocks acetylcholine release at the neuromuscular junction, the chemical signal that tells a muscle to contract. Published reviews of the mechanism of botulinum toxin type A describe how interrupting that signal relaxes the treated muscle for a period, after which nerve signaling gradually returns and movement comes back.
The drying method does not change that core mechanism. Vacuum drying versus freeze drying is a manufacturing and formulation difference, framed by makers as affecting purity, residue, and handling, not the way the toxin acts on the nerve. Kamomis was in clinical trials and export-licensed at the time of its brochure, so treat its specific claims as newer and less independently studied than longtime brands.
What should you expect, and what is worth tracking?
A clear timeline and an honest record. The relaxing effect builds over days, then fades over weeks to months, so the comparison that matters is session to session. If you want to weigh drying methods, our post on Toxpia covers another product that leans on the vacuum-dried angle, which makes for a fair side-by-side.
What should the record actually contain? Start with how long results lasted for you. The durations you read about are averages drawn from large groups, and your own number may land higher or lower. Note the date the effect began to ease and count back to your last session to learn your personal range.
Photos earn their keep only when they are consistent. Use the same angle, the same lighting, and a neutral expression every time, ideally at a similar hour of the day. A matched before-and-after pair beats memory or a flattering glance in the mirror. Mismatched, casual snapshots tend to mislead more than they inform.
A short self-rating before your next appointment rounds it out. Score how relaxed the area still feels and note whether you would repeat the same plan. Because Kamomis leans on newer, less independently studied claims, recording the brand and batch matters even more. If you later switch products, that note is what lets you compare one toxin against another honestly.
This is the kind of cycle Dosefi is built to track. Add Kamomis as a treatment, log each session with its date and a photo, set a reminder for when results typically start to ease, and let your self-rated notes build a trend over time. For broader context, see how long does Botox last.
A grounded takeaway
Kamomis is Maypharm’s vacuum-dried botulinum toxin type A in a 100-unit vial, marketed around purity, low residue, and consistency. Treat those claims as the manufacturer’s framing rather than proven advantages, keep a dated record, and leave candidacy, dosing, and the procedure to a licensed professional. The official guide is attached for your reference.
Sources
- “Botulinum Toxin Type A” pharmacology review (PMC). Peer-reviewed overview of how botulinum toxin type A blocks acetylcholine release at the neuromuscular junction.
